Theravance Bio Ord (TBPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TBPH | CRON | SPRY | ||
| Company | Theravance Bio Ord | Cronos Group Inc | Ars Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 19.42 | 2.70 | 9.36 | ||
| High | 19.94 | 2.74 | 9.42 | ||
| Low | 19.16 | 2.68 | 8.86 | ||
| Latest | 19.67 | 2.71 | 8.96 | ||
| Change | +0.24 | +0.01 | -0.48 | ||
| % Change | +1.24% | +0.37% | -5.08% | ||
| Volume | 292,692 | 1,018,366 | 564,411 | ||
| 20-Day Average Volume | 399,841 | 1,331,756 | 1,204,070 | ||
| Previous Close | 19.43 | 2.70 | 9.44 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 19.57 | 2.63 | 9.79 | ||
| 20-Day Raw Stochastic | 49.47% | 76.74% | 14.98% | ||
| 20-Day Relative Strength | 52.68 | 55.17 | 41.33 | ||
| Weighted Alpha | +110.18 | +24.52 | -34.15 | ||
| Today's Opinion | 96% Buy | 72% Buy | 88% Sell | ||
| Previous Opinion | 80% Buy | 64% Buy | 88% Sell | ||
| Last Month's Opinion | 100% Buy | 72% Buy | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.16% since 02/12/26 | +6.23% since 02/12/26 | +1.59% since 02/12/26 | ||
| Low | 18.69 on 02/17/26 | 2.58 on 02/17/26 | 8.61 on 02/13/26 | ||
| High | 20.40 on 02/17/26 | 2.74 on 02/20/26 | 9.64 on 02/19/26 | ||
| 1-Month | |||||
| %Chg | -3.89% since 01/20/26 | +7.06% since 01/20/26 | -14.35% since 01/20/26 | ||
| Low | 18.45 on 02/11/26 | 2.40 on 02/02/26 | 8.61 on 02/13/26 | ||
| High | 21.03 on 01/22/26 | 2.83 on 01/23/26 | 10.88 on 01/23/26 | ||
| 3-Month | |||||
| %Chg | +9.64% since 11/20/25 | +18.70% since 11/20/25 | +32.99% since 11/20/25 | ||
| Low | 17.25 on 12/17/25 | 2.28 on 11/21/25 | 6.66 on 11/21/25 | ||
| High | 21.03 on 01/22/26 | 3.43 on 12/15/25 | 13.15 on 01/12/26 | ||
| 6-Month | |||||
| %Chg | +46.56% since 08/20/25 | +12.81% since 08/20/25 | -38.70% since 08/20/25 | ||
| Low | 13.37 on 08/21/25 | 2.28 on 11/21/25 | 6.66 on 11/21/25 | ||
| High | 21.03 on 01/22/26 | 3.43 on 12/15/25 | 15.09 on 08/21/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 984,557 | 1,026,421 | 933,134 | ||
| Shares Outstanding, K | 50,672 | 380,156 | 98,849 | ||
| Annual Sales | 64,380,000 | 117,620,000 | 89,150,000 | ||
| Annual Net Income | -56,420,000 | 41,080,000 | 8,000,000 | ||
| Last Quarter Sales | 19,990,000 | 36,340,000 | 32,500,000 | ||
| Last Quarter Net Income | 3,620,000 | -6,570,000 | -51,150,000 | ||
| 60-Month Beta | 0.15 | 0.80 | 0.79 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.04 on 11/10/25 | 0.07 on 11/06/25 | -0.52 on 11/10/25 | ||
| Latest Earnings Date | 02/25/26 | 02/26/26 | 03/19/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 40.79 | 0.00 | 0.00 | ||